Exalys Therapeutics
San Diego, US · Founded 2018 · Delaware corporation · 2 known investors
Find your way into Exalys Therapeutics
Sign up to see every warm intro you have to Exalys Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Exalys Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
EW
Eckard Weber, M.D.Named on SEC filing
MS
Michael SandersNamed on SEC filing
NV
Nicole VitulloNamed on SEC filing
DP

RO
Rick OrrNamed on SEC filing
LR
Lynne RollinsNamed on SEC filing
Board
TT

BT
Investors · 2
Catalys PacificreportedTokyovia Brian Taylor Slingsby · board
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Domain AssociatesreportedPrinceton · $200K – $15M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$4M disclosed across 1 round · 2020
▶$4MraisedApr 2020 · 2 investors · PharmaceuticalsRule 506(b)
▶$4MraisedApr 2020 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Takeshi TakahashiDirector
- Eckard Weber, M.D.Director
- Michael SandersExecutive Officer
- Nicole VitulloDirector
- Dennis PodlesakExecutive Officer, Director
- Brian Taylor SlingsbyDirector
- Rick OrrDirector
- Lynne RollinsExecutive Officer
- Offering amount
- $25M
- Amount sold
- $4M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Exalys Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are Exalys Therapeutics's investors?
- Exalys Therapeutics's investors include Catalys Pacific, Domain Associates.
- How much funding has Exalys Therapeutics raised?
- Exalys Therapeutics has disclosed $4M raised across 1 round.
- Where is Exalys Therapeutics headquartered?
- Exalys Therapeutics is headquartered in San Diego, US.